ES2104223T3 - 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. - Google Patents
2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.Info
- Publication number
- ES2104223T3 ES2104223T3 ES94105859T ES94105859T ES2104223T3 ES 2104223 T3 ES2104223 T3 ES 2104223T3 ES 94105859 T ES94105859 T ES 94105859T ES 94105859 T ES94105859 T ES 94105859T ES 2104223 T3 ES2104223 T3 ES 2104223T3
- Authority
- ES
- Spain
- Prior art keywords
- benzmidazole
- isobutyl
- amino
- methyl
- bencilsulfinil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 AMINO Chemical class 0.000 title 1
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 239000004599 antimicrobial Substances 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
- 206010019375 Helicobacter infections Diseases 0.000 abstract 1
- 208000028861 Helicobacter pylori infectious disease Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
EL 2[[2-(N-ISOBUTIL-N-METIL)AMINO]-BENCILSULFINILO]BENCIMIDAZOL ES EFECTIVO EN EL TRATAMIENTO O PREVENCION DE INFECCIONES DE HELICOBACTER MEDIANTE ADMINISTRACION A PACIENTES QUE SUFREN SU INFECCION.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5113942A JPH06298611A (ja) | 1993-04-16 | 1993-04-16 | 抗菌剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2104223T3 true ES2104223T3 (es) | 1997-10-01 |
Family
ID=14625066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94105859T Expired - Lifetime ES2104223T3 (es) | 1993-04-16 | 1994-04-15 | 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5576341A (es) |
| EP (1) | EP0621035B1 (es) |
| JP (1) | JPH06298611A (es) |
| DE (1) | DE69404200T2 (es) |
| ES (1) | ES2104223T3 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2150274C1 (ru) * | 1996-12-26 | 2000-06-10 | Бачин Игорь Валентинович | Стабилизированная водорастворимая композиция трийодида 1,2,3-триалкилбензимидазолия |
| RU2135476C1 (ru) * | 1998-12-07 | 1999-08-27 | Ливицкий Василий Иванович | Дийодбромиды 1,2,3-замещенных бензимидазолия и их водорастворимая композиция |
| SE9904044D0 (sv) * | 1999-11-09 | 1999-11-09 | Astra Ab | Compounds |
| EP2147679B1 (en) | 2001-07-25 | 2014-06-25 | Raptor Pharmaceutical, Inc. | Compositions for blood-brain barrier transport |
| JP3958748B2 (ja) * | 2004-02-20 | 2007-08-15 | 株式会社日本生物科学研究所 | 抗菌剤 |
| EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
| CN101594878A (zh) | 2006-09-18 | 2009-12-02 | 雷普特药品公司 | 通过给予受体相关蛋白(rap)-缀合物对肝病症的治疗 |
| PL3395372T3 (pl) | 2009-02-20 | 2022-07-25 | EnhanX Biopharm Inc. | Układ do dostarczania leków na bazie glutationu |
| CN102458374A (zh) | 2009-05-06 | 2012-05-16 | 实验室护肤股份有限公司 | 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4640985A (en) * | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
| EP0439453B1 (en) * | 1987-10-12 | 1994-01-19 | Exomed Australia Pty. Ltd. (ACN 051 976 446) | Improved method for treatment of gastrointestinal disorders |
| ES2066120T3 (es) * | 1989-02-10 | 1995-03-01 | Takeda Chemical Industries Ltd | Uso de derivados de bencimidazol como agentes antibacterianos. |
| JPH03161440A (ja) * | 1989-11-17 | 1991-07-11 | Yoshitomi Pharmaceut Ind Ltd | 抗菌剤 |
-
1993
- 1993-04-16 JP JP5113942A patent/JPH06298611A/ja active Pending
-
1994
- 1994-04-15 DE DE69404200T patent/DE69404200T2/de not_active Expired - Fee Related
- 1994-04-15 EP EP94105859A patent/EP0621035B1/en not_active Expired - Lifetime
- 1994-04-15 ES ES94105859T patent/ES2104223T3/es not_active Expired - Lifetime
- 1994-04-18 US US08/228,750 patent/US5576341A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69404200D1 (de) | 1997-08-21 |
| US5576341A (en) | 1996-11-19 |
| EP0621035B1 (en) | 1997-07-16 |
| JPH06298611A (ja) | 1994-10-25 |
| EP0621035A1 (en) | 1994-10-26 |
| DE69404200T2 (de) | 1998-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU8335291A (en) | Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals | |
| CO4970691A1 (es) | Terapia en combinacion para erradicar vhc-arn detectable en pacientes que padecen infeccion de hepatitis c cronica | |
| KR950002785A (ko) | 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜 | |
| KR890004709A (ko) | 항원충제로서의 아지트로마이신 및 이의 유도체 | |
| RU94041223A (ru) | Средство для лечения мотонейроновых заболеваний | |
| PT880350E (pt) | Tratamento de esclerose multipla | |
| PL310474A1 (en) | Application of rilusole in treating neuro-aids diseases | |
| BR0013010A (pt) | Formulação de cloreto de sódio de moxifloxacina | |
| MX9100042A (es) | Reduccion o prevencion de irritacion de la piel por drogas | |
| BR9916114A (pt) | Uso de apomorfina na fabricação de um medicamento para tratamento de disfunção erétil orgânica masculina | |
| EP0699439A3 (en) | Treatment of diseases caused by sebum with inhibitors of acyl CoA cholesterol acyltransferase | |
| ES2104223T3 (es) | 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. | |
| BR9406059A (pt) | Composição farmacéutica e método para tratamento de uma infecção helmintica em um animal | |
| SE9601395D0 (sv) | New therapeutic treatment 1 | |
| EP0744176A3 (en) | Methods for inhibiting bone loss | |
| BR0115215A (pt) | Método para o tratamento de inflamações | |
| EP1073436A4 (en) | IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI | |
| DE69739482D1 (de) | Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen | |
| ES2170377T3 (es) | Composicion que contiene quitosana. | |
| CO5031290A1 (es) | Formulacion lo | |
| ATE83657T1 (de) | Pharmazeutische zusammensetzung. | |
| CO4600680A1 (es) | Procedimientos para la prevencion de la degradacion de la proteina c | |
| KR970704442A (ko) | 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia) | |
| MD196C2 (ro) | Izonicotinoilhidrazonă a aldehidei 5-nitro-2-furanice | |
| WO1999065511A3 (en) | Composition and method for treatment of pseudomonas infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 621035 Country of ref document: ES |